These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8439687)

  • 1. Population pharmacokinetics: development of a medical intensive care unit-specific gentamicin dosing nomogram.
    Watling SM; Kisor DF
    Ann Pharmacother; 1993 Feb; 27(2):151-4. PubMed ID: 8439687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of gentamicin. Use of the nonparametric expectation maximisation (NPEM) algorithm.
    Kisor DF; Watling SM; Zarowitz BJ; Jelliffe RW
    Clin Pharmacokinet; 1992 Jul; 23(1):62-8. PubMed ID: 1617859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of gentamicin: evaluation of five nomograms for initial dosing at Al-Amiri Hospital in Kuwait.
    Al-Lanqawi Y; Capps P; Abdel-hamid M; Abulmalek K; Phillips D; Matar K; Sharma P; Thusu A
    Med Princ Pract; 2007; 16(5):348-54. PubMed ID: 17709922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive performance of gentamicin dosing nomograms.
    Lee J; Yoon S; Shin D; Han H; An H; Lee J; Lim KS; Yu KS; Lee H
    Drug Des Devel Ther; 2014; 8():1097-106. PubMed ID: 25152616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of four once-daily aminoglycoside dosing nomograms.
    Wallace AW; Jones M; Bertino JS
    Pharmacotherapy; 2002 Sep; 22(9):1077-83. PubMed ID: 12222541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of six gentamicin nomograms using a bayesian parameter estimation program.
    Thomson AH; Campbell KC; Kelman AW
    Ther Drug Monit; 1990 May; 12(3):258-63. PubMed ID: 2349609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
    Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
    Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates.
    DiCenzo R; Forrest A; Slish JC; Cole C; Guillet R
    Pharmacotherapy; 2003 May; 23(5):585-91. PubMed ID: 12741432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian pharmacokinetics of gentamicin in a haemodialysis population.
    Vercaigne LM; Ariano RE; Zacharias JM
    Clin Pharmacokinet; 2004; 43(3):205-10. PubMed ID: 14871157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia.
    Frymoyer A; Meng L; Bonifacio SL; Verotta D; Guglielmo BJ
    Pharmacotherapy; 2013 Jul; 33(7):718-26. PubMed ID: 23553582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating new and traditional methods for aminoglycoside dosing in patients with various degrees of renal function.
    Tsubaki T; Chandler MH
    Pharmacotherapy; 1994; 14(3):330-6. PubMed ID: 7937274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.
    Kirkpatrick CM; Duffull SB; Begg EJ
    Br J Clin Pharmacol; 1999 Jun; 47(6):637-43. PubMed ID: 10383541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
    Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
    Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
    Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
    Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
    Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
    Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily gentamicin dosing in pediatric patients without cystic fibrosis.
    McDade EJ; Wagner JL; Moffett BS; Palazzi DL
    Pharmacotherapy; 2010 Mar; 30(3):248-53. PubMed ID: 20180608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin.
    Burton ME; Chow MS; Platt DR; Day RB; Brater DC; Vasko MR
    Clin Pharm; 1986 Feb; 5(2):143-9. PubMed ID: 3754192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter evaluation of gentamicin therapy in the neonatal intensive care unit.
    Glover ML; Shaffer CL; Rubino CM; Cuthrell C; Schoening S; Cole E; Potter D; Ransom JL; Gal P
    Pharmacotherapy; 2001 Jan; 21(1):7-10. PubMed ID: 11191739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.